Side Effects As with the GLP-1 mimickers currently on the market, gastrointestinal side effects were commonly reported including nausea, vomiting, diarrhea, and constipation, and they were more often associated with dose increases
The lead program in the collaboration is a once-monthly GLP-1 receptor agonist product candidate that will initially target obesity and type 2 diabetes
The fulfillment process maintains batch continuity tracking, and cold-chain packaging is provided when temperature-sensitive shipping is required
None of this is a schedule anyone can follow these were protocol-defined regimens given to screened participants under investigator supervision
*Correspondence: Yongye Huang, [email protected] This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Cell and Developmental Biology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
